Subclinical spinal muscular atrophy in a 60-year-old man

被引:0
作者
Palma, Sandra [1 ]
Pereira, Pedro [1 ]
机构
[1] Hosp Garcia Orta Portugal, Ave Torrado Silva, P-2805267 Almada, Portugal
关键词
Spinal muscular atrophy; Type; 4; Subclinical; SMN1; DELETIONS; GENE;
D O I
10.1016/j.nmd.2024.05.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Spinal muscular atrophy is an autosomal recessive genetic disease that can manifest with different phenotypes, classified as types 1 to 4, being type 4 the mildest form. We report a case of a 60-yearold man presenting with sudden onset of numbness in the right upper limb and with a family history of a 48-year-old brother with progressive weakness. At the first visit, his exam was unremarkable, except for a mild paresis of the right elbow extension and reduced right bicipital and tricipital reflexes. Electromyography revealed chronic motor neuronopathy and the genetic study confirmed a diagnosis of spinal muscular atrophy. At the follow-up visit his complains improved and his neurologic exam returned to normal. To our knowledge, this patient is the oldest asymptomatic SMA individual ever reported. This case highlights the need to exclude late onset spinal muscular atrophy in patients with indolent motor neuronopathy. (c) 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:42 / 45
页数:4
相关论文
共 50 条
  • [41] Autosomal dominant congenital spinal muscular atrophy: a true form of spinal muscular atrophy caused by early loss of anterior horn cells
    Oates, Emily C.
    Reddel, Stephen
    Rodriguez, Michael L.
    Gandolfo, Luke C.
    Bahlo, Melanie
    Hawke, Simon H.
    Lamande, Shireen R.
    Clarke, Nigel F.
    North, Kathryn N.
    BRAIN, 2012, 135 : 1714 - 1723
  • [42] Comprehensive Modeling of Spinal Muscular Atrophy in Drosophila melanogaster
    Spring, Ashlyn M.
    Reimer, Amanda C.
    Hamilton, Christine D.
    Schillinger, Michela J.
    Matera, A. Gregory
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [43] Funding for spinal muscular atrophy research must continue
    Bowerman, Melissa
    FUTURE NEUROLOGY, 2019, 14 (02)
  • [44] Pathogenesis and therapeutic targets in spinal muscular atrophy (SMA)
    Lefebvre, S.
    Sarret, C.
    ARCHIVES DE PEDIATRIE, 2020, 27 (07): : 3 - 8
  • [45] Spinal muscular atrophy - new therapies, new challenges
    Jedrzejowska, Maria
    Kostera-Pruszczyk, Anna
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2020, 54 (01) : 8 - 13
  • [46] Clinical manifestations of spinal muscular atrophy in adult patients
    Horak, T.
    Bednarik, J.
    Horakova, M.
    Botikova, D.
    Vohanka, S.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2020, 83 : S13 - S16
  • [47] Pathogenesis of proximal autosomal recessive spinal muscular atrophy
    Simic, Goran
    ACTA NEUROPATHOLOGICA, 2008, 116 (03) : 223 - 234
  • [48] Spinal muscular atrophy: diagnosis, treatment and future prospects
    Baioni, Mariana T. C.
    Ambiel, Celia R.
    JORNAL DE PEDIATRIA, 2010, 86 (04) : 261 - 270
  • [49] Antisense oligonucleotides and spinal muscular atrophy: skipping along
    Burghes, Arthur H. M.
    McGovern, Vicki L.
    GENES & DEVELOPMENT, 2010, 24 (15) : 1574 - 1579
  • [50] Spinal muscular atrophy: Clinical classification and disease heterogeneity
    Russman, Barry S.
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (08) : 946 - 951